Clinical Trials Logo
  1. Home
  2. Corticobasal Syndrome (CBS)
  3. NCT02966145

4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2 — 4RTNI-2  

Progressive Supranuclear Palsy (PSP) Clinical Trial

Official title:
The Four-Repeat Tauopathy Neuroimaging Initiative

Clinical Trial Summary

The goal of this study is to identify the most reliable methods of analysis for tracking CBD, PSP, and o/vPSP over time. The results from this study may be used in the future to calculate statistical power for clinical drug trials. The study will also provide information about the relative value of novel imaging techniques for diagnosis, as well as the value of imaging techniques versus testing of blood, urine, and cerebrospinal fluid (CSF) 'biomarkers'.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02966145
Study type Observational
Source University of California, San Francisco
Contact
Status Active, not recruiting
Phase
Start date January 2016
Completion date December 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT02365922 - Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Recruiting NCT03030586 - ADDIA Proof-of-Performance Clinical Study
Recruiting NCT02778607 - PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK
Completed NCT02531360 - Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies Phase 0
Completed NCT02133846 - Safety Study of TPI-287 to Treat CBS and PSP Phase 1
Recruiting NCT04363684 - ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Completed NCT04193527 - A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients Phase 3
Completed NCT02839642 - Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy Phase 3
Terminated NCT03391765 - An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP) Phase 2
Completed NCT02103894 - Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects Phase 1
Active, not recruiting NCT04539041 - Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy Phase 1
Completed NCT01888185 - Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)
Completed NCT03545126 - Human CNS Tau Kinetics in Tauopathies
Completed NCT03413319 - Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104 Phase 1